Header Logo

Connection

ALEXANDER LAZAR to Mitogen-Activated Protein Kinase 3

Back to Details
This is a "connection" page, showing publications ALEXANDER LAZAR has written about Mitogen-Activated Protein Kinase 3.
ALEXANDER LAZAR
Connection Strength
0.032
Mitogen-Activated Protein Kinase 3
  1. Clinical, Molecular, and Immune Analysis of Dabrafenib-Trametinib Combination Treatment for BRAF Inhibitor-Refractory Metastatic Melanoma: A Phase 2 Clinical Trial. JAMA Oncol. 2016 Aug 01; 2(8):1056-64.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.